These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

Archives: Search / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005 / 2004 / 2003 / 2002 / 2001 / 2000 / 1999

2012 Archives

Dec 18, 2012
System to be installed in Rio de Janeiro next year
Dec 14, 2012
Dec 3, 2012
Nov 29, 2012
Advanced Capabilities of Varian's Market-Leading Cancer Treatment Systems on Display at AROICON 2012 in Kolkata, November 30th-December 2nd
Nov 29, 2012
Nov 20, 2012
Varian will also sponsor a luncheon seminar about techniques for targeting tumors that move during treatment due to breathing
Nov 20, 2012
Nov 13, 2012
Nov 12, 2012
Nov 5, 2012
Nov 5, 2012
Oct 31, 2012
Oct 31, 2012
Oct 30, 2012
FullScale oncology IT solutions offer enhanced computing power for users of the ARIA® oncology information system and Eclipse™ treatment planning
Oct 29, 2012
Oct 28, 2012
EDGE integrates new real-time tumor tracking in end-to-end system for performing radiosurgery anywhere in the body where radiation is indicated
Oct 25, 2012
Net earnings per diluted share from continuing operations rise to $1.08 for the fourth quarter and to $3.76 for fiscal year 2012; revenues rise to $756 million for the fourth quarter and to $2.8 billion for the fiscal year
Oct 25, 2012
Oct 23, 2012
Oct 22, 2012
Company will unveil new technologies as well as a portfolio of comprehensive oncology IT solutions
Oct 17, 2012
Oct 15, 2012
Liver cancer patients among the first to receive treatment using fast, precise new system optimized for radiosurgery
Oct 10, 2012
Oct 2, 2012
Paper in the Journal of Thoracic and Cardiovascular Surgery summarizes ongoing clinical trial in order to increase awareness of this important study
Oct 1, 2012
 
Contact Investor Relations

Varian Corporate Headquarters
Tel: 650-424-5834
Fax: 650-424-6822
E-mail: investors@varian.com

Follow Varian Medical Systems on TwitterFollow us on Twitter